Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.105
-0.035 (-3.07%)
Mar 26, 2026, 10:38 AM EDT - Market open

RANI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
1.21.03--2.720.46
Revenue Growth (YoY)
----488.10%-52.81%
Gross Profit
1.21.03--2.720.46
Selling, General & Admin
20.1123.9526.4826.8427.834.96
Research & Development
22.1126.6839.6236.6126.4812.04
Other Operating Expenses
3.713.71----
Total Operating Expenses
45.9354.3466.163.4554.3217.01
Operating Income
-44.73-53.31-66.1-63.45-51.6-16.54
Interest Income
0.81.763.31.250.090.06
Interest Expense
-3.67-5.03-5.09-1.07-0.47-0.12
Other Non-Operating Income (Expense)
-----1.07-0.06
Total Non-Operating Income (Expense)
-2.87-3.27-1.780.18-1.45-0.12
Pretax Income
-47.6-56.58-67.88-63.27-53.05-16.67
Provision for Income Taxes
----0.07-0.04-0.04
Net Income
-28.32-30.02-33.97-30.59-8.33-33.41
Minority Interest in Earnings
19.2826.5733.9132.7644.7616.7
Net Income to Common
-28.32-30.02-33.97-30.59-8.33-33.41
Shares Outstanding (Basic)
372826242047
Shares Outstanding (Diluted)
372826242047
Shares Change (YoY)
39.24%11.65%7.09%21.93%-58.34%-
EPS (Basic)
-0.79-1.05-1.33-1.28-0.43-0.36
EPS (Diluted)
-0.79-1.05-1.33-1.28-0.43-0.36
Free Cash Flow
--35.76-52.47-48.13-32.75-16.16
Free Cash Flow Per Share
--1.26-2.06-2.02-1.68-0.34
Gross Margin
100.00%100.00%--100.00%100.00%
Operating Margin
-3727.75%-5186.19%---1899.12%-3580.95%
Profit Margin
-3966.50%-5504.28%---1953.92%-3615.37%
FCF Margin
--3478.99%---1205.41%-3497.84%
EBITDA
-44.73-52.29-65.28-62.9-51.1-15.96
EBITDA Margin
-3727.75%-5086.19%---1880.82%-3453.46%
EBIT
-44.73-53.31-66.1-63.45-51.6-16.54
EBIT Margin
-3727.75%-5186.19%---1899.12%-3580.95%
Effective Tax Rate
-0.00%0.00%0.11%0.08%0.21%
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q